Market Research Logo

Veterinary Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2016 – 2026

Veterinary Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2016 – 2026

This Future Market Insights report examines the ‘Global Veterinary Vaccines Market’ for the period 2016–2026. The primary objective of the report is to offer updates, trends, drivers, restraints, volume and value forecasts and opportunities for manufacturers operating in the global veterinary vaccines market.

Global demand for veterinary vaccines is increasing as a result of improving food security, Improving public health through controlling contagious diseases such as avian influenza, Increasing foodborne and zoonotic diseases and Rising humanization of pets and adoption. Markets in developed economies are witnessing increasing demand for veterinary vaccines due to rising adoption of tried and tested products and the trend is expected to boost the overall demand for veterinary vaccines such as e attenuated live vaccines during the forecast period. To understand and assess the opportunities in this market, the report is categorically split into four sections, namely market analysis by product type, disease application type, animal type, distribution type and region. The report analyses the global veterinary vaccines market in terms of market value (US$ Mn).

The report starts with an overview of the veterinary vaccines market and its usage in various applications globally. In the same section, FMI covers the veterinary vaccines market performance in terms of revenue. This section includes FMI’s analysis of key trends, drivers and restraints from the supply and demand side perspective.

The next section of the report analyses the market based on product type and presents the forecast in terms of value for the next 10 years. Product types covered in the report include:

Attenuated Live Vaccines Market
Conjugate Vaccines Market
Inactivated Vaccines Market
Subunit Vaccines Market
Toxoid Vaccines Market
DNA Vaccines Market
Recombinant Vaccines Market

The next section of the report analyses the market based on disease application type segments and presents the forecast in terms of value for the next ten years. The disease application type segments covered in the report include:

Anaplasmosis
Canine Parvovirus
Foot and Mouth Disease
New Castle Disease
Distemper Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others

The next section of the report analyses the market based on animal type segments and presents the forecast in terms of value for the next ten years. The animal type segments covered in the report include:

Companion Animals
Canine
Avine
Feline
Livestock Animals
Aquatic
Bovine
Porcine
Ovine
Poultry
Equine

The next section of the report analyses the market based on distribution channel segments and presents the forecast in terms of value for the next ten years. The distribution channel segments covered in the report include:

Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Retail Pharmacies

Furthermore, the report analyses the market based on regions and presents the forecast in terms of value for the next ten years. Regions covered in the report include:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Middle East & Africa (MEA)
Japan

The forecast presented for the market assesses the total revenue generated in the veterinary vaccines market. When developing the forecast, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. Given the characteristics of market, we triangulated the outcome based on different analysis of the supply side, demand side and GDP growth rate. However, quantifying the market across aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalising them after the forecast has been completed.

In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global veterinary vaccines market.

As previously highlighted, the global veterinary vaccines market is split into various categories based on region, product type, animal type and application type and distribution channel type. All these segments or categories have been analyzed in terms of Basis Point Share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the global veterinary vaccines market.

Another key feature of this report is the analysis of the veterinary vaccines market by region and product type, animal type and application type and distribution channel type; and the market revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global veterinary vaccines market.


1. Executive Summary
2. Research Methodology
3. Assumptions & Acronyms Used
4. Definition and Taxonomy
4.1.Market Definition
4.2.Taxonomy
5. Market Dynamics
5.1.Introduction
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunity
5.1.4. Trends
5.1.5. Regulations
6. Overall Market Outlook
6.1.Section Summary
6.2.Global Veterinary Vaccines Market Forecast, 2015-2026
6.3.Introduction
6.3.1. Y-o-Y Growth Projection
6.3.2. Absolute $ Opportunity
7. Global Veterinary Vaccines Market Analysis, By Product Type
7.1. Introduction
7.1.1. Global Veterinary Vaccines Market Overview
7.1.2. Global Veterinary Vaccines Market Value Share, by Product Type
7.1.3. Global Veterinary Vaccines Market Attractiveness by Product Type
7.1.4. Y-o-Y Growth Comparison, By Product Type
7.2. Market Value Forecast, By Product Type
7.2.1. Attenuated Live Vaccines
7.2.1.1. Absolute $ Opportunity
7.2.1.2. Market Value Forecast
7.2.2. Inactivated Vaccines
7.2.2.1. Absolute $ Opportunity
7.2.2.2. Market Value Forecast
7.2.3. Subunit Vaccines
7.2.3.1. Absolute $ Opportunity
7.2.3.2. Market Value Forecast
7.2.4. Toxoid Vaccines
7.2.4.1. Absolute $ Opportunity
7.2.4.2. Market Value Forecast
7.2.5. DNA Vaccines
7.2.5.1. Absolute $ Opportunity
7.2.5.2. Market Value Forecast
7.2.6. Recombinant Vaccines
7.2.6.1. Absolute $ Opportunity
7.2.6.2. Market Value Forecast
7.3. Global Veterinary Vaccines Market Trends, by Product Type
8. Global Veterinary Vaccines Market Analysis, By Diseases
8.1. Introduction
8.1.1. Overview
8.1.2. Global Veterinary Vaccines Market Value Share, by Diseases
8.1.3. Global Veterinary Vaccines Market Attractiveness by Diseases
8.1.4. Y-o-Y Growth Comparison, By Diseases
8.2. Market Value Forecast, By Diseases
8.2.1. Anaplasmosis
8.2.1.1. Absolute $ Opportunity
8.2.1.2. Market Value Forecast
8.2.2. Canine Parvovirus
8.2.2.1. Absolute $ Opportunity
8.2.2.2. Market Value Forecast
8.2.3. Foot & Mouth Disease
8.2.3.1. Absolute $ Opportunity
8.2.3.2. Market Value Forecast
8.2.4. Newcastle Disease
8.2.4.1. Absolute $ Opportunity
8.2.4.2. Market Value Forecast
8.2.5. Distemper Disease
8.2.5.1. Absolute $ Opportunity
8.2.5.2. Market Value Forecast
8.2.6. Influenza Disease
8.2.6.1. Absolute $ Opportunity
8.2.6.2. Market Value Forecast
8.2.7. Porcine Reproductive & Respiratory Syndrome (PRRS) Disease
8.2.7.1. Absolute $ Opportunity
8.2.7.2. Market Value Forecast
8.2.8. Others Disease
8.2.8.1. Absolute $ Opportunity
8.2.8.2. Market Value Forecast
8.3. Global Veterinary Vaccines Market Trends, by Diseases
9. Global Veterinary Vaccines Market Analysis, By Species Type
9.1. Introduction
9.1.1. Overview
9.1.2. Global Veterinary Vaccines Market Value Share, by Species Type
9.1.3. Global Veterinary Vaccines Market Attractiveness By Species Type
9.1.4. Y-o-Y Growth Comparison, By Species Type
9.2. Market Value Forecast, By Species Type
9.2.1. Companion Animal
9.2.1.1. Market Value Forecast
9.2.1.1.1. Canine
9.2.1.1.2. Avian
9.2.1.1.3. Feline
9.2.2. Livestock Animals
9.2.2.1. Market Value Forecast
9.2.2.1.1. Aquatic
9.2.2.1.2. Bovine
9.2.2.1.3. Porcine
9.2.2.1.4. Ovine/Caprine
9.2.2.1.5. Poultry
9.2.3. Equine
9.2.3.1. Absolute $ Opportunity
9.2.3.2. Market Value Forecast
9.3. Global Veterinary Vaccines Market Trends, by Species Type
10. Global Veterinary Vaccines Market Analysis, By Distribution Channel
10.1. Introduction
10.1.1. Global Veterinary Vaccines Market Value Share, by Distribution Channel
10.1.2. Global Veterinary Vaccines Market Attractiveness by Distribution Channel
10.1.3. Y-o-Y Growth Comparison, By Distribution Channel
10.2. Market Value Forecast, By Distribution Channel
10.2.1. Veterinary Clinic Segment
10.2.1.1. Absolute $ Opportunity
10.2.1.2. Market Value Forecast
10.2.2. Veterinary Hospital Segment
10.2.2.1. Absolute $ Opportunity
10.2.2.2. Market Value Forecast
10.2.3. Veterinary Research Institute
10.2.3.1. Absolute $ Opportunity
10.2.3.2. Market Value Forecast
10.2.4. Retail Pharmacies
10.2.4.1. Absolute $ Opportunity
10.2.4.2. Market Value Forecast
10.3. Global Veterinary Vaccines Market Trends, by Distribution Channel
10.4. Global Veterinary Vaccines Market Trends, by Diseases
11. Global Veterinary Vaccines Market Analysis, By Region
11.1. Introduction
11.1.1. Global Veterinary Vaccines Market Value Share, by Region
11.1.2. Global Veterinary Vaccines Market Attractiveness by Region
11.2. Market Value Forecast, By Region
11.2.1. North America
11.2.2. Latin America
11.2.3. Western Europe
11.2.4. Eastern Europe
11.2.5. APEJ
11.2.6. Japan
11.2.7. MEA
12. North America Veterinary Vaccines Market Analysis
12.1. Introduction
12.1.1. North America Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
12.1.2. North America Veterinary Vaccines Market Absolute $ Opportunity
12.1.3. Market Value Forecast
12.1.3.1. By Country
12.1.3.1.1. U.S.
12.1.3.1.2. Canada
12.1.3.2. By Product Type
12.1.3.2.1. Attenuated Live Vaccines
12.1.3.2.2. Conjugate Vaccines
12.1.3.2.3. Inactivated Vaccines
12.1.3.2.4. Subunit Vaccines
12.1.3.2.5. Toxoid Vaccines
12.1.3.2.6. DNA Vaccines
12.1.3.2.7. Recombinant Vaccines
12.1.3.3. By Diseases Type
12.1.3.3.1. Anaplasmosis
12.1.3.3.2. Canine Parvovirus
12.1.3.3.3. Foot & Mouth Disease
12.1.3.3.4. New Castle Disease
12.1.3.3.5. Distemper Disease
12.1.3.3.6. Influenza
12.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
12.1.3.3.8. Others
12.1.3.4. By Distribution Channel
12.1.3.4.1. Veterinary Clinics
12.1.3.4.2. Veterinary Hospitals
12.1.3.4.3. Veterinary Research Institutes
12.1.3.4.4. Retail Pharmacies & Others
12.1.3.5. By Species Type
12.1.3.5.1. Companion Animals
12.1.3.5.1.1. Canine
12.1.3.5.1.2. Avian
12.1.3.5.1.3. Feline
12.1.3.5.2. Livestock Animals
12.1.3.5.2.1. Aquatic
12.1.3.5.2.2. Bovine
12.1.3.5.2.3. Porcine
12.1.3.5.2.4. Ovine/Caprine
12.1.3.5.2.5. Poultry
12.1.3.5.3. Equine
12.1.4. North America Veterinary Vaccines Market Attractiveness
12.1.4.1. By Country
12.1.4.2. By Product Type
12.1.4.3. By Diseases
12.1.4.4. By Distribution Channel
12.1.4.5. By Species Type
12.2. Drivers and Restraints Impact Analysis
13. Latin America Veterinary Vaccines Market Analysis
13.1. Introduction
13.1.1. Latin America Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
13.1.2. Latin America Veterinary Vaccines Market Absolute $ Opportunity
13.1.3. Market Value Forecast
13.1.3.1. By Country
13.1.3.1.1 Argentina
13.1.3.1.2. Brazil
13.1.3.1.3. Mexico
13.1.3.1.4. Rest of Latin America
13.1.3.2. By Product Type
13.1.3.2.1. Attenuated Live Vaccines
13.1.3.2.2. Conjugate Vaccines
13.1.3.2.3. Inactivated Vaccines
13.1.3.2.4. Subunit Vaccines
13.1.3.2.5. Toxoid Vaccines
13.1.3.2.6. DNA Vaccines
13.1.3.2.7. Recombinant Vaccines
13.1.3.3. By Diseases Type
13.1.3.3.1. Anaplasmosis
13.1.3.3.2. Canine Parvovirus
13.1.3.3.3. Foot & Mouth Disease
13.1.3.3.4. New Castle Disease
13.1.3.3.5. Distemper Disease
13.1.3.3.6. Influenza
13.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
13.1.3.3.8. Others
13.1.3.4. By Distribution Channel
13.1.3.4.1. Veterinary Clinics
13.1.3.4.2. Veterinary Hospitals
13.1.3.4.3. Veterinary Research Institutes
13.1.3.4.4. Retail Pharmacies & Others
13.1.3.5. By Species Type
13.1.3.5.1. Companion Animals
13.1.3.5.1.1. Canine
13.1.3.5.1.2. Avian
13.1.3.5.1.3. Feline
13.1.3.5.2. Livestock Animals
13.1.3.5.2.1. Aquatic
13.1.3.5.2.2. Bovine
13.1.3.5.2.3. Porcine
13.1.3.5.2.4. Ovine/Caprine
13.1.3.5.2.5. Poultry
13.1.3.5.3.Equine
13.1.4. Latin America Veterinary Vaccines Market Attractiveness
13.1.4.1. By Country
13.1.4.2. By Product Type
13.1.4.3. By Diseases
13.1.4.4. By Distribution Channel
13.1.4.5. By Species Type
13.2. Drivers and Restraints Impact Analysis
14. Western Europe Veterinary Vaccines Market Analysis
14.1. Introduction
14.1.1. Western Europe Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
14.1.2. Western Europe Veterinary Vaccines Market Absolute $ Opportunity
14.1.3. Market Value Forecast
14.1.3.1. By Country
14.1.3.1.1. Germany
14.1.3.1.2. Italy
14.1.3.1.3. France
14.1.3.1.4. UK
14.1.3.1.5. Spain
14.1.3.1.6. NORDIC Countries
14.1.3.1.7. Benelux
14.1.3.1.8. Rest of Western Europe
14.1.3.2. By Product Type
14.1.3.2.1. Attenuated Live Vaccines
14.1.3.2.2. Conjugate Vaccines
14.1.3.2.3. Inactivated Vaccines
14.1.3.2.4. Subunit Vaccines
14.1.3.2.5. Toxoid Vaccines
14.1.3.2.6. DNA Vaccines
14.1.3.2.7. Recombinant Vaccines
14.1.3.3. By Diseases Type
14.1.3.3.1. Anaplasmosis
14.1.3.3.2. Canine Parvovirus
14.1.3.3.3. Foot & Mouth Disease
14.1.3.3.4. New Castle Disease
14.1.3.3.5. Distemper Disease
14.1.3.3.6. Influenza
14.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
14.1.3.3.8. Others
14.1.3.4. By Distribution Channel
14.1.3.4.1. Veterinary Clinics
14.1.3.4.2. Veterinary Hospitals
14.1.3.4.3. Veterinary Research Institutes
14.1.3.4.4. Retail Pharmacies & Others
14.1.3.5. By Species Type
14.1.3.5.1. Companion Animals
14.1.3.5.1.1. Canine
14.1.3.5.1.2. Avian
14.1.3.5.1.3. Feline
14.1.3.5.2. Livestock Animals
14.1.3.5.2.1. Aquatic
14.1.3.5.2.2. Bovine
14.1.3.5.2.3. Porcine
14.1.3.5.2.4. Ovine/Caprine
14.1.3.5.2.5. Poultry
14.1.3.5.3. Equine
14.1.4. Western Europe Veterinary Vaccines Market Attractiveness
14.1.4.1. By Country
14.1.4.2. By Product Type
14.1.4.3. By Diseases
14.1.4.4. By Distribution Channel
14.1.4.5. By Species Type
14.2. Drivers and Restraints Impact Analysis
15. Eastern Europe Veterinary Vaccines Market Analysis
15.1. Introduction
15.1.1. Eastern Europe Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
15.1.2. Eastern Europe Veterinary Vaccines Market Absolute $ Opportunity
15.1.3. Market Value Forecast
15.1.3.1. By Country
15.1.3.1.1. Russia
15.1.3.1.2. Poland
15.1.3.1.3. Rest of Eastern Europe
15.1.3.2. By Product Type
15.1.3.2.1. Attenuated Live Vaccines
15.1.3.2.2. Conjugate Vaccines
15.1.3.2.3. Inactivated Vaccines
15.1.3.2.4. Subunit Vaccines
15.1.3.2.5. Toxoid Vaccines
15.1.3.2.6. DNA Vaccines
15.1.3.2.7. Recombinant Vaccines
15.1.3.3. By Diseases Type
15.1.3.3.1. Anaplasmosis
15.1.3.3.2. Canine Parvovirus
15.1.3.3.3. Foot & Mouth Disease
15.1.3.3.4. New Castle Disease
15.1.3.3.5. Distemper Disease
15.1.3.3.6. Influenza
15.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
15.1.3.3.8. Others
15.1.3.4. By Distribution Channel
15.1.3.4.1. Veterinary Clinics
15.1.3.4.2. Veterinary Hospitals
15.1.3.4.3. Veterinary Research Institutes
15.1.3.4.4. Retail Pharmacies & Others
15.1.3.5. By Species Type
15.1.3.5.1. Companion Animals
15.1.3.5.1.1. Canine
15.1.3.5.1.2. Avian
15.1.3.5.1.3. Feline
15.1.3.5.2. Livestock Animals
15.1.3.5.2.1. Aquatic
15.1.3.5.2.2. Bovine
15.1.3.5.2.3. Porcine
15.1.3.5.2.4. Ovine/Caprine
15.1.3.5.2.5. Poultry
15.1.3.5.3. Equine
15.1.4. Eastern Europe Veterinary Vaccines Market Attractiveness
15.1.4.1. By Country
15.1.4.2. By Product Type
15.1.4.3. By Diseases
15.1.4.4. By Distribution Channel
15.1.4.5. By Species Type
15.2. Drivers and Restraints Impact Analysis
16. APEJ Veterinary Vaccines Market Analysis
16.1. Introduction
16.1.1. APEJ Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
16.1.2. APEJ Veterinary Vaccines Market Absolute $ Opportunity
16.1.3. Market Value Forecast
16.1.3.1. By Country
16.1.3.1.1. Greater China
16.1.3.1.2. India
16.1.3.1.3. ASEAN
16.1.3.1.4. Australia and NZ
16.1.3.1.5. Rest of APEJ
16.1.3.2. By Product Type
16.1.3.2.1. Attenuated Live Vaccines
16.1.3.2.2. Conjugate Vaccines
16.1.3.2.3. Inactivated Vaccines
16.1.3.2.4. Subunit Vaccines
16.1.3.2.5. Toxoid Vaccines
16.1.3.2.6. DNA Vaccines
16.1.3.2.7. Recombinant Vaccines
16.1.3.3. By Diseases Type
16.1.3.3.1. Anaplasmosis
16.1.3.3.2. Canine Parvovirus
16.1.3.3.3. Foot & Mouth Disease
16.1.3.3.4. New Castle Disease
16.1.3.3.5. Distemper Disease
16.1.3.3.6. Influenza
16.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
16.1.3.3.8. Others
16.1.3.4. By Distribution Channel
16.1.3.4.1. Veterinary Clinics
16.1.3.4.2. Veterinary Hospitals
16.1.3.4.3. Veterinary Research Institutes
16.1.3.4.4. Retail Pharmacies & Others
16.1.3.5. By Species Type
16.1.3.5.1. Companion Animals
16.1.3.5.1.1. Canine
16.1.3.5.1.2. Avian
16.1.3.5.1.3. Feline
16.1.3.5.2. Livestock Animals
16.1.3.5.2.1. Aquatic
16.1.3.5.2.2. Bovine
16.1.3.5.2.3. Porcine
16.1.3.5.2.4. Ovine/Caprine
16.1.3.5.2.5. Poultry
16.1.3.5.3. Equine
16.1.4. APEJ Veterinary Vaccines Market Attractiveness
16.1.4.1. By Country
16.1.4.2. By Product Type
16.1.4.3. By Diseases
16.1.4.4. By Distribution Channel
16.1.4.5. By Species Type
16.2. Drivers and Restraints Impact Analysis
17. JAPAN Veterinary Vaccines Market Analysis
17.1. Introduction
17.1.1. JAPAN Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
17.1.2. JAPAN Veterinary Vaccines Market Absolute $ Opportunity
17.1.3. Market Value Forecast
17.1.3.1. By Product Type
17.1.3.1.1. Attenuated Live Vaccines
17.1.3.1.2. Conjugate Vaccines
17.1.3.1.3. Inactivated Vaccines
17.1.3.1.4. Subunit Vaccines
17.1.3.1.5. Toxoid Vaccines
17.1.3.1.6. DNA Vaccines
17.1.3.1.7. Recombinant Vaccines
17.1.3.2. By Diseases Type
17.1.3.2.1. Anaplasmosis
17.1.3.2.2. Canine Parvovirus
17.1.3.2.3. Foot & Mouth Disease
17.1.3.2.4. New Castle Disease
17.1.3.2.5. Distemper Disease
17.1.3.2.6. Influenza
17.1.3.2.7 Porcine Reproductive & Respiratory Syndrome (PRRS)
17.1.3.2.8. Others
17.1.3.3. By Distribution Channel
17.1.3.3.1. Veterinary Clinics
17.1.3.3.2. Veterinary Hospitals
17.1.3.3.3. Veterinary Research Institutes
17.1.3.3.4. Retail Pharmacies & Others
17.1.3.4. By Species Type
17.1.3.4.1. Companion Animals
17.1.3.4.1.1. Canine
17.1.3.4.1.2. Avian
17.1.3.4.1.3. Feline
17.1.3.4.2. Livestock Animals
17.1.3.4.2.1. Aquatic
17.1.3.4.2.2. Bovine
17.1.3.4.2.3. Porcine
17.1.3.4.2.4. Ovine/Caprine
17.1.3.4.2.5. Poultry
17.1.3.4.3. Equine
17.1.4. JAPAN Veterinary Vaccines Market Attractiveness
17.1.4.1. By Country
17.1.4.2. By Product Type
17.1.4.3. By Diseases
17.1.4.4. By Distribution Channel
17.1.4.5. By Species Type
17.2. Drivers and Restraints Impact Analysis
18. MEA Veterinary Vaccines Market Analysis
18.1. Introduction
18.1.1. MEA Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
18.1.2. MEA Veterinary Vaccines Market Absolute $ Opportunity
18.1.3. Market Value Forecast
18.1.3.1. By Country
18.1.3.1.1. GCC Countries
18.1.3.1.2. South Africa
18.1.3.1.3. Rest of MEA
18.1.3.2. By Product Type
18.1.3.2.1. Attenuated Live Vaccines
18.1.3.2.2. Conjugate Vaccines
18.1.3.2.3. Inactivated Vaccines
18.1.3.2.4. Subunit Vaccines
18.1.3.2.5. Toxoid Vaccines
18.1.3.2.6. DNA Vaccines
18.1.3.2.7. Recombinant Vaccines
18.1.3.3. By Diseases Type
18.1.3.3.1. Anaplasmosis
18.1.3.3.2. Canine Parvovirus
18.1.3.3.3. Foot & Mouth Disease
18.1.3.3.4. New Castle Disease
18.1.3.3.5. Distemper Disease
18.1.3.3.6. Influenza
18.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
18.1.3.3.8. Others
18.1.3.4. By Distribution Channel
18.1.3.4.1. Veterinary Clinics
18.1.3.4.2. Veterinary Hospitals
18.1.3.4.3. Veterinary Research Institutes
18.1.3.4.4. Retail Pharmacies & Others
18.1.3.5. By Species Type
18.1.3.5.1. Companion Animals
18.1.3.5.1.1. Canine
18.1.3.5.1.2. Avian
18.1.3.5.1.3. Feline
18.1.3.5.2. Livestock Animals
18.1.3.5.2.1. Aquatic
18.1.3.5.2.2. Bovine
18.1.3.5.2.3. Porcine
18.1.3.5.2.4. Ovine/Caprine
18.1.3.5.2.5. Poultry
18.1.3.5.3. Equine
18.1.4. MEA Veterinary Vaccines Market Attractiveness
18.1.4.1. By Country
18.1.4.2. By Product Type
18.1.4.3. By Diseases
18.1.4.4. By Distribution Channel
18.1.4.5. By Species Type
18.1.5. Drivers and Restraints Impact Analysis
19. Competition Landscape
19.1. Competition Dashboard
19.2. Company Profiles
19.2.1. Revenue
19.2.2. Product Types/Brand Offerings
19.2.3. Key developments
19.2.4. SWOT Analysis
19.3. Company Highlights
19.3.1. Merial
19.3.2. Zoetis
19.3.3. Elanco
19.3.4. Merck & Co. Inc
19.3.5. Borhinger Inghlem
19.3.6. Bayer Phsrms Ag
19.3.7. Ceva
19.3.8. Verbs

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report